Allow at least 4 to 6 weeks at a stable retatrutide dose before drawing conclusions about your cardiovascular response
However, the enhanced weight loss from the combination could lead to more pronounced fluid and electrolyte shifts that indirectly affect heart rate and blood pressure
Compare that to stopping prescription GLP-1 medication, where weight regain is well-documented
Wharton S, Calanna S, Davies M, Dicker D, Goldman B, Lingvay I, et al
In September 2025 , Eli Lilly and Company invested $6.5 billion to build a new manufacturing facility in Houston, Texas, dedicated to producing its experimental oral GLP-1 pill, orforglipron
Laboratory handling requires adherence to sterile preparation and once weekly injection standards to maintain sample integrity